![]() |
市场调查报告书
商品编码
1775448
全球呼吸照护设备市场:2025-2030 年预测Global Respiratory Care Devices Market - Forecasts from 2025 to 2030 |
呼吸护理设备市场预计将从 2025 年的 253.75 亿美元成长到 2030 年的 356.5 亿美元,复合年增长率为 7.04%。
老年人口不断增加
全球人口老化是市场扩张的主要催化剂。老年人更容易患慢性阻塞性肺病(COPD) 等慢性呼吸系统疾病,这显着增加了对呼吸照护设备的需求。日本和义大利等老年人口比例居世界首位的地区,对与老龄化相关的疾病的医疗保健需求正在增加。这些人口结构变化给医疗保健系统带来了采用先进呼吸护理技术的压力,从而推动了预测期内(2023-2028 年)的市场成长。老年人群中非传染性疾病盛行率的上升,进一步推动了对有效管理慢性呼吸系统疾病的创新设备的需求。
慢性阻塞性肺病盛行率不断上升
慢性阻塞性肺病 (COPD) 仍然是市场需求的主要驱动力,该疾病目前无法治疗方法,但可以透过先进的呼吸人工呼吸器和其他呼吸支持设备的需求。由于 COPD 在老年人中更为普遍,全球人口老化将加剧这一趋势,从而进一步推动市场成长。
早产儿数量激增
早产儿增加也是推动新生儿呼吸照护设备需求的关键因素。早产儿,尤其是32週前出生的早产儿,常因肺表面活性物质分泌不足而出现呼吸系统疾病,引发早产儿呼吸暂停、支气管肺发育不良和肺炎等疾病。根据世界卫生组织统计,全球每年约有1500万例早产,其中60%以上发生在非洲和南亚地区。中低收入国家的早产率(12%)高于高所得国家(9%)。降低呼吸系统併发症导致的新生儿死亡率的需求推动了对先进呼吸护理设备的需求,创造了巨大的市场机会。
市场区隔
技术进步
智慧通气解决方案的创新正在改变呼吸护理设备市场。先进的系统可以根据医生指定的目标和患者的生理输入自动调节通气和供氧量。这些技术正在提高易用性,改善患者预后,并推动收益的显着成长。此类先进设备的开发代表着巨大的市场扩张机会,尤其对于患有急性或慢性呼吸系统疾病的患者。
区域洞察
由于慢性阻塞性肺病 (COPD) 等慢性呼吸系统疾病的发生率高且医疗支出高昂,北美占据了主导市场占有率。另一方面,由于需要呼吸支持的慢性疾病负担沉重且老年人口众多(尤其是在日本),亚太地区是成长最快的市场。这种区域动态凸显了全球市场的各种成长机会。
市场挑战
严格的法规环境
由于医疗设备认证的严格监管要求,市场面临挑战。 FDA 归类为 II 类的呼吸照护器材需要透过上市前通知 (510(k))核准。虽然这些法规确保了安全性,但它们可能会延迟产品上市或增加开发成本,从而阻碍市场成长。在构思、製造、包装和广告方面,严格的查核点旨在防止误导性宣传,但也可能导致产品合格,进而影响市场动态。
它有什么用途?
产业和市场考量、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响
The Global Respiratory Care Devices Market is expected to grow from USD 25.375 billion in 2025 to USD 35.650 billion in 2030, at a CAGR of 7.04%.
Rising Geriatric Population
The global aging population is a major catalyst for market expansion. The elderly are more susceptible to chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD), which significantly boosts demand for respiratory care devices. Japan, with the world's highest proportion of elderly individuals, and other regions like Italy, are seeing increased healthcare needs for age-related conditions. This demographic shift places pressure on health systems to adopt advanced respiratory care technologies, propelling market growth over the forecast period (2023-2028). The rising prevalence of non-communicable diseases among older populations further amplifies the need for innovative devices to manage chronic respiratory conditions effectively.
Increasing Prevalence of COPD
COPD remains a critical driver of market demand, with no cure but treatable through advanced respiratory care devices. Smoking, both active and passive, is a leading cause of COPD, alongside other risk factors like indoor and outdoor pollution and occupational exposures to dust and chemicals. The disease's high prevalence, particularly in low- and middle-income countries, fuels the need for ventilators and other respiratory support devices. The aging global population exacerbates this trend, as COPD is more common among older individuals, further accelerating market growth.
Surge in Preterm Births
The rising incidence of preterm births is another significant factor driving demand for neonatal respiratory care devices. Premature infants, particularly those born before 32 weeks, often suffer from respiratory disorders due to insufficient surfactant production, leading to conditions like apnea of prematurity, bronchopulmonary dysplasia, and pneumonia. According to WHO, approximately 15 million preterm births occur annually, with over 60% in African and South Asian regions. Low- and middle-income countries report higher preterm birth rates (12%) compared to high-income countries (9%). The need to reduce neonatal mortality from respiratory complications has spurred demand for advanced respiratory care devices, creating substantial market opportunities.
Market Segment Analysis
Technological Advancements
Innovations in intelligent ventilation solutions are transforming the respiratory care devices market. Advanced systems can automatically adjust ventilation and oxygenation based on physician-specified goals and patient physiological inputs. These technologies enhance ease of use and improve patient outcomes, driving significant revenue growth. The development of such sophisticated devices presents a robust opportunity for market expansion, particularly for patients with acute or chronic respiratory conditions.
Regional Insights
North America holds a dominant market share due to the high prevalence of chronic respiratory diseases like COPD and substantial healthcare expenditure. Meanwhile, the Asia-Pacific region is the fastest-growing market, driven by a high burden of chronic diseases requiring respiratory support and a significant elderly population, particularly in Japan. These regional dynamics highlight varied growth opportunities across global markets.
Market Challenges
Stringent Regulatory Environment
The market faces challenges due to rigorous regulatory requirements for medical device approvals. Respiratory care devices, classified as Class II devices by the FDA, require premarket notification (510(k)) clearance. These regulations ensure safety but can delay product launches and increase development costs, posing a barrier to market growth. Stringent checkpoints during conception, manufacturing, packaging, and advertising aim to prevent misleading claims but may lead to product disqualifications, impacting market dynamics.
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence
Segmentation: